Cargando…

ITGB3BP is a potential biomarker associated with poor prognosis of glioma

Despite the growing recognition of ITGB3BP as an essential feature of various cancers, the relationship between ITGB3BP and glioma remains unclear. The main aim of this study was to determine the prognostic and diagnostic value of ITGB3BP in glioma. RNA‐Seq and microarray data from 2222 glioma patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhendong, Liu, Binfeng, Bian, Lu, Wang, Hongbo, Jia, Yulong, Wang, Yubo, Zhang, Wang, Wang, Yanbiao, Han, Zhibin, Cheng, Xingbo, Lian, Xiaoyu, Ren, Zhishuai, Gao, Yanzheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817129/ https://www.ncbi.nlm.nih.gov/pubmed/34953037 http://dx.doi.org/10.1111/jcmm.17127

Ejemplares similares

Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients
por: Liu, Zhendong, et al.
Publicado: (2021)

Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cells
por: Liu, Zhendong, et al.
Publicado: (2021)

Overexpression of GINS4 is associated with poor prognosis and survival in glioma patients
por: Liu, Binfeng, et al.
Publicado: (2021)

Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients
por: Wang, Jialin, et al.
Publicado: (2021)

ELK3: A New Molecular Marker for the Diagnosis and Prognosis of Glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

Interleukin-1 receptor-associated kinase 4 as a potential biomarker: Overexpression predicts poor prognosis in patients with glioma
por: Wang, Jialin, et al.
Publicado: (2021)

DRAXIN as a Novel Diagnostic Marker to Predict the Poor Prognosis of Glioma Patients
por: Jia, Yulong, et al.
Publicado: (2022)

Cysteine cathepsin C: a novel potential biomarker for the diagnosis and prognosis of glioma
por: Cheng, Xingbo, et al.
Publicado: (2022)

GNG5 is a novel oncogene associated with cell migration, proliferation, and poor prognosis in glioma
por: Zhang, Wang, et al.
Publicado: (2021)

GNG12 as A Novel Molecular Marker for the Diagnosis and Treatment of Glioma
por: Liu, Runze, et al.
Publicado: (2022)

High expression of HOXA4 in patients with glioma indicates unfavorable clinical outcomes
por: Yu, Zhenghong, et al.
Publicado: (2022)

COL4A1 as a novel oncogene associated with the clinical characteristics of malignancy predicts poor prognosis in glioma
por: Wang, Hongbo, et al.
Publicado: (2021)

ESPL1 Is a Novel Prognostic Biomarker Associated With the Malignant Features of Glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value
por: Zhang, Bo, et al.
Publicado: (2021)

Prognostic significance of HSF2BP in lung adenocarcinoma
por: Huang, Zhendong, et al.
Publicado: (2021)

ZNF480 influences the prognosis, pathogenesis, and immune microenvironment in patients with lower-grade glioma
por: Zhu, Qingyun, et al.
Publicado: (2023)

Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer
por: Liu, Dongliang, et al.
Publicado: (2022)

Identification of key genes and small molecule drugs in osteoarthritis by integrated bioinformatics analysis
por: Liu, Zhendong, et al.
Publicado: (2023)

Exploring the relationship between abnormally high expression of NUP205 and the clinicopathological characteristics, immune microenvironment, and prognostic value of lower-grade glioma
por: Liang, Wenjia, et al.
Publicado: (2023)

Integrated profiling identifies ITGB3BP as prognostic biomarker for hepatocellular carcinoma
por: Liang, Qiuli, et al.
Publicado: (2021)

Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy
por: Hu, Li, et al.
Publicado: (2021)

Comprehensive analysis of fatty acid metabolism-related gene signatures for predicting prognosis in patients with prostate cancer
por: Wang, Hongbo, et al.
Publicado: (2023)

Cemented versus uncemented hemiarthroplasty for elderly patients with displaced fracture of the femoral neck: A PRISMA-compliant meta-analysis of randomized controlled trial
por: Liu, Binfeng, et al.
Publicado: (2020)

Correlation between ITGB2 expression and clinical characterization of glioma and the prognostic significance of its methylation in low-grade glioma(LGG)
por: Liu, He, et al.
Publicado: (2023)

Transcriptomic analysis reveals high ITGB1 expression as a predictor for poor prognosis of pancreatic cancer
por: Iwatate, Yosuke, et al.
Publicado: (2022)

EZH2 overexpression is associated with poor prognosis in patients with glioma
por: Zhang, Yanyang, et al.
Publicado: (2016)

Dissecting and analyzing the Subclonal Mutations Associated with Poor Prognosis in Diffuse Glioma
por: Bai, Ming, et al.
Publicado: (2022)

Melusin gene (ITGB1BP2) nucleotide variations study in hypertensive and cardiopathic patients
por: Palumbo, Valeria, et al.
Publicado: (2009)

Upregulation of nectin-4 is associated with ITGB1 and vasculogenic mimicry and may serve as a predictor of poor prognosis in colorectal cancer
por: Zhang, Jinxiu, et al.
Publicado: (2019)

Expression and clinical significance of UBE2V1 in cervical cancer
por: Ren, Zhishuai, et al.
Publicado: (2021)

High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma
por: Zhang, Chunzhi, et al.
Publicado: (2012)

Biomechanical Comparison of a New Memory Compression Alloy Plate versus Traditional Titanium Plate for Anterior Cervical Discectomy and Fusion: A Finite Element Analysis
por: Liu, Jiantao, et al.
Publicado: (2020)

Coexisting EGFR and TP53 Mutations in Lung Adenocarcinoma Patients Are Associated With COMP and ITGB8 Upregulation and Poor Prognosis
por: Zheng, Chang, et al.
Publicado: (2020)

The Tropomyosin Family as Novel Biomarkers in Relation to Poor Prognosis in Glioma
por: Huang, Ke, et al.
Publicado: (2022)

LILRB3 suppresses immunity in glioma and is associated with poor prognosis
por: Zhuang, Qiyuan, et al.
Publicado: (2023)

Biomechanical properties of a novel nonfusion artificial vertebral body for anterior lumbar vertebra resection and internal fixation
por: Liu, Jiantao, et al.
Publicado: (2021)

4E-BP1(Thr46) Phosphorylation Association with Poor Prognosis in Quantitative Phosphoproteomics of Portal Vein Tumor Thrombus Revealed that 4E-BP1Thr46 Phosphorylation is Associated with Poor Prognosis in HCC
por: Lin, Xincong, et al.
Publicado: (2020)

TGIF1 overexpression promotes glioma progression and worsens patient prognosis
por: Wang, Baoya, et al.
Publicado: (2022)

The expression and significance of long non-coding RNA ITGB2-AS1 in renal clear cell carcinoma
por: Zhou, Wei, et al.
Publicado: (2023)

ITGB1-mediated molecular landscape and cuproptosis phenotype induced the worse prognosis in diffuse gastric cancer
por: Zhu, Xingyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jg6uo71edoqg949d8pa1cho1vf